Showing results (301-310 of 435) with videos related to

Sort By:
Pageof 44
Signal Transduction and Targeted Therapy|May 13, 2023
Immunosenescence: molecular mechanisms and diseasesZaoqu Liu, Qimeng Liang, Yuqing Ren, et al.
Scientific Reports|July 2, 2025
Phase II study of transcatheter arterial chemoembolization (TACE) combined with apatinib for advanced perihilar cholangiocarcinomaHao Li, Pengfei Chen, Mengfan Zhang, et al.
Imeta|June 13, 2024
Immune-related interaction perturbation networks unravel biological peculiars and clinical significance of glioblastomaZaoqu Liu, Yudi Xu, Yuhui Wang, et al.
Annals of Clinical Microbiology and Antimicrobials|June 2, 2026
Comparative evaluation of tigecycline susceptibility testing methods for carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumanniiYu Shi, Shaozeng Li, Lijing He, et al.
Frontiers in Medicine|January 31, 2022
Molecular Characterization and Clinical Relevance of ALDH2 in Human CancersBo Ma, Zaoqu Liu, Hui Xu, et al.
BMC Cancer|August 14, 2023
CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdownNannan Zhao, Siyuan Weng, Zaoqu Liu, et al.
Medicine|March 17, 2021
Development and validation of a robust immune-related risk signature for hepatocellular carcinomaZaoqu Liu, Dechao Jiao, Long Liu, et al.
Tissue Engineering. Part A|August 10, 2021
Hydroxypropyl Chitosan/Soy Protein Isolate Conduits Promote Peripheral Nerve RegenerationYanan Zhao, Chuan Tian, Ping Wu, et al.
Frontiers in Immunology|August 1, 2022
Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical ApplicationZaoqu Liu, Ying Kong, Qin Dang, et al.
Computational and Structural Biotechnology Journal|March 23, 2022
Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancerLibo Wang, Zaoqu Liu, Rongtao Zhu, et al.
Pageof 44